The government has purchased 1.2 million doses of Covid-19 vaccines developed by three vaccine developers — China National Pharmaceutical Group (also known as Sinopharm), Germany’s BioNTech and the Anglo-Swedish joint venture of AstraZeneca and Oxford University
